Mukka Proteins Limited's Board approved acquiring 1,000 additional equity shares in Ento Proteins Private Limited for Rs. 32.30 lakhs on February 12, 2026, increasing shareholding from 74.01% to 100%. EPPL, a manufacturer of insect meal and insect oil incorporated in 2021, reported turnover of Rs. 7.46 crores and PAT of Rs. 49.47 lakhs in FY 2024-25. The cash acquisition, scheduled for completion by June 30, 2026, aligns with Mukka Proteins' strategy to expand its alternate proteins business segment.
Mukka Proteins Limited Approves Acquisition to Make Ento Proteins Wholly Owned Subsidiary
Mukka Proteins Limited announced that its Board of Directors has approved the acquisition of additional equity shares in subsidiary company Ento Proteins Private Limited (EPPL) during a meeting held on February 12, 2026. The strategic move will transform EPPL into a wholly owned subsidiary of the fish meal and fish oil manufacturer.
Acquisition Details
The Board approved the acquisition of 1,000 equity shares of face value Rs. 100 each in EPPL for a total consideration of Rs. 32,30,000. The shares will be acquired from existing shareholders through a cash transaction.
Parameter: Details Shares Acquired: 1,000 equity shares Face Value: Rs. 100 per share Total Consideration: Rs. 32,30,000 Payment Method: Cash Completion Timeline: June 30, 2026
Shareholding Structure Changes
The acquisition will significantly alter Mukka Proteins' ownership structure in EPPL, increasing its control substantially.
Shareholding Metric: Current Post-Acquisition Change Ownership Percentage: 74.01% 100.00% +25.99% Status: Subsidiary Wholly Owned Subsidiary Enhanced Control
Target Company Profile
Ento Proteins Private Limited operates in the alternative proteins sector, specializing in insect-based products. The company was incorporated on March 8, 2021, and has demonstrated consistent growth in its business operations.
Financial Parameter: Amount Authorized Capital: Rs. 10,00,000 Paid-up Capital: Rs. 3,84,700 FY 2024-25 Turnover: Rs. 7,46,27,305 FY 2024-25 PAT: Rs. 49,47,474
Business Performance Trajectory
EPPL has shown steady revenue growth over the past three years in the insect meal and insect oil manufacturing segment:
Year: Turnover March 2023: Rs. 4,72,20,140 March 2024: Rs. 6,44,38,907 March 2025: Rs. 7,46,27,305
Strategic Rationale
The acquisition forms part of Mukka Proteins' strategic investment plans to expand its alternate proteins business. EPPL's specialization in insect meal and insect oil manufacturing complements the parent company's existing portfolio in the protein sector. The transaction is being conducted on an arm's length basis, with EPPL classified as a related party due to its subsidiary status.
Regulatory Compliance
The Board meeting, which commenced at 4:00 p.m. and concluded at 4:45 p.m., was conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. No governmental or regulatory approvals are required for completing this acquisition. The company has provided comprehensive disclosures as mandated under Schedule III of the Listing Regulations.
Mukka Proteins Limited has reached a major milestone in its sustainability journey with the formal listing of its Black Soldier Fly (BSF) project on the Verra Registry. The company's 300 TPD wet-waste processing operations in Bengaluru have been registered under Project ID 5893, marking significant progress toward carbon credit generation.
Verra Registry Listing and Validation Process
The BSF-driven municipal wet-waste processing initiative, currently operational under the company's empanelment with Bengaluru Solid Waste Management Limited, has entered the mandatory 30-day public comment period following its Verra listing. This represents the next formal step in Verra's carbon credit registration workflow.
Project Parameter: Details Project ID: 5893 Current Capacity: 300 TPD Methodology: ACM0022 Program: Verra Verified Carbon Standard (VCS) Status: Public comment period (30 days)
Following the public comment period, an accredited validation and verification body will conduct on-site assessment and prepare the final validation report to complete the VCS registration cycle. VCU eligibility currently applies specifically to the 300 TPD operational BSF facility, with performance monitoring and validation activities underway.
Capacity Expansion Approval
Mukka Proteins has received incremental approval to expand its processing capacity significantly within Bengaluru's integrated waste-management framework. The expansion represents a substantial increase from the previously announced 200-300 TPD capacity.
Capacity Details: Current Approved Expansion Processing Capacity: 300 TPD Up to 1,000 TPD Initial Approval: August 2025 January 2026 Structure: Single phase Grouped project
The project is structured as a grouped project under the VCS program, enabling phased inclusion of additional processing modules. As each phase of the expanded capacity becomes operational and validated, additional carbon credits will be generated and registered according to Verra's validation and verification requirements.
Strategic Impact and Future Potential
The phased structure ensures that while current 300 TPD operations advance toward carbon credit issuance, future capacity additions up to 1,000 TPD will support progressively larger VCU generation. This approach strengthens long-term sustainability and revenue-diversification potential for the company.
Mr. Kalandan Mohammed Haris, CEO & MD, commented on the development: "The listing of our Bengaluru BSF project on the Verra Registry marks a key advancement in our carbon credit roadmap. While carbon certification is underway for the ongoing 300 TPD operations, our newly approved pathway to scale up to 1,000 TPD positions us to expand this platform significantly over the coming phases."
Company Background
Mukka Proteins Limited operates as one of India's prominent manufacturers and exporters of fishmeal, fish oil, and fish-soluble paste. The company maintains a strong export presence across 25+ countries with diversified operations in India and the Middle East. Key operational highlights include:
Market share of 25-30% in India's fishmeal and fish oil market
Installed capacity of 2,64,390 MT per year across fish meal, fish oil and fish soluble paste
Recognition as 311th in FT1000 High Growth Companies Asia-Pacific 2025 edition
Strategic manufacturing and blending facilities for supply reliability
The BSF project represents the company's expansion into waste-to-value solutions and circular-economy technology, complementing its core aquaculture and animal nutrition business segments.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation. We plan to change that - a technology-led platform built for super traders and long term investors.